Respimat

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Its developer, Boehringer Ingelheim, is currently[when?] conducting approved in the U.S. with a variety of their products, such as Spiriva (tiotropium bromide) and Combivent (ipratropium bromde/albuterol).

References[edit]

Sources[edit]